Title |
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis
|
---|---|
Published by |
John Wiley & Sons, Ltd, October 2014
|
DOI | 10.1002/14651858.cd010247.pub2 |
Pubmed ID | |
Authors |
Pandey, Sanjay, Rathore, Chaturbhuj, Michael, Benedict D |
Abstract |
Viral encephalitis is characterised by diverse clinical and epidemiological features. Seizures are an important clinical manifestation and associated with increased mortality and morbidity. Patients may have seizures during the acute illness or they may develop after recovery. There are no recommendations regarding the use of antiepileptic drugs for the primary or secondary prevention of seizures in patients with viral encephalitis. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 36 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 14% |
Student > Bachelor | 5 | 14% |
Student > Master | 4 | 11% |
Student > Doctoral Student | 3 | 8% |
Other | 3 | 8% |
Other | 9 | 24% |
Unknown | 8 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 57% |
Neuroscience | 3 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Agricultural and Biological Sciences | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Other | 2 | 5% |
Unknown | 6 | 16% |